MacroGenics
MGNX
#8794
Rank
โ‚น23.04 B
Marketcap
โ‚น361.77
Share price
5.35%
Change (1 day)
132.98%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น49.67

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น55.14. In 2025 the company made an earnings per share (EPS) of -โ‚น114.14 a decrease over its 2024 EPS that were of -โ‚น103.50.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น49.67-56.49%
2025-โ‚น114.1410.28%
2024-โ‚น103.50613.33%
2023-โ‚น14.51-92.31%
2022-โ‚น188.62-42.14%
2021-โ‚น325.9836.44%
2020-โ‚น238.92-21.84%
2019-โ‚น305.67-24.58%
2018-โ‚น405.30675.93%
2017-โ‚น52.23-68.05%
2016-โ‚น163.47168.25%
2015-โ‚น60.94-55%
2014-โ‚น135.423400%
2013-โ‚น3.87-108.68%
2012โ‚น44.5924.49%
2011โ‚น35.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น73.51-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,891-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,569-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น251.50 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น122.41-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น439.15-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น209.90 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA